Our Very Own Superhero
At just 6 years old, Zachary is dealing with hep C stigma and the letdown of failed treatment. Join Kim Bossley in raising awareness about his fight.
How do you eat healthy for hepatitis C when you have no choice but drive-thru fast food? Karen Hoyt has some tips.
New Drugs, Bad Journalism
Lucinda K. Porter is feeling a bit defensive about new hep C treatments, which recently made headlines in a disparaging way.
No More Riba or Interferon!
Connie Welch overviews yet another new generation of hep C drugs, which are expected to hit the market by 2014.
Joe Burke talks about the bullying he experienced for having hemophilia, hep C and HIV throughout childhood — and how his faith overcame it.
Eye of the Tiger
The potential for millions to benefit from new hep C meds makes this one of the most exciting moments in modern medicine.
Sov-Ledipasvir Better for Livers
In a recent trial, those who took the combo had a 43-60% reduced rate of cirrhosis, liver cancer and transplant when compared to patients on older therapies.
Re-testing for Hepatitis C
For people living with HIV, follow-up hep C screenings are relatively uncommon, despite an increased risk of infection.
Choose the Right Doctor
Considering treatment for hepatitis C? Here’s a guide to finding the right clinician.
Your Hep C Genotype Matters
New studies show higher cirrhosis and liver cancer risks for geno 3’s.
Coinfected? Check Out ‘3D’
Abbvie’s new combo regimen shows 93-96 percent cures for patients living with both hep C and HIV in recent trials.
Faster, Easier Hep C Cures
Say goodbye to months of painful drug injections, side effects and failed cure attempts. New drugs are 90% to 100% effective and work in 12 weeks!
In the current issue, hep C advocate Lucinda Porter on how she overcame hepatitis C and ended up helping others fight it, too.
Real World Adherence
A new CVS study reveals more than 8% of hep C patients taking Sovaldi aren’t keeping up with treatment.
Prices Keep Going Up
Experts say the upcoming sofosbuvir/ledipasvir combo pill will probably be even more expensive than existing Sovaldi treatments.
People at Risk
Viral hepatitis among the world’s native populations is hugely prevalent, incredibly understudied and vastly unaddressed.
Youth at Risk
Hep C, heroin and the prescription painkiller epidemics are all peaking among Americans under 30. Here’s how they’re connected, and how to stop them.
Your Online Hepatitis Community
Check out what everyone's talking about in the Hep Forums.